Literature DB >> 430360

The anaerobic metabolism of metronidazole forms N-(2-hydroxyethyl)-oxamic acid.

R L Koch, P Goldman.   

Abstract

N-(2-hydroxyethyl)-oxamic acid is formed when metronidazole is reduced either chemically or by the action of the intestinal bacteria. When metronidazole, labeled with carbon-14 in the hydroxyethyl side chain, is administered by gavage to rats in doses of 200 mg/kg, an average of 1.4% of the administered radioactivity is recovered in the urine in the form of N-(2-hydroxyethyl)-oxamic acid. The presence of conjugated N-(2-hydroxyethyl)-oxamic acid in some samples was suggested by the detection of small additional amounts of the free acid after treatment of the urine with beta-glucuronidase. The metabolite is not found in the feces. In contrast N-(2-hydroxyethyl)-oxamic acid is not found in the urine or feces of germfree rats which receive metronidazole. Thus, the finding of N-(2-hydroxyethyl)-oxamic acid in the urine of rats which receive metronidazole appears to depend on the activity of the bacterial flora.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 430360

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  16 in total

Review 1.  Challenges and emerging systems biology approaches to discover how the human gut microbiome impact host physiology.

Authors:  Gordon Qian; Joshua W K Ho
Journal:  Biophys Rev       Date:  2020-07-07

Review 2.  Gut microbiome interactions with drug metabolism, efficacy, and toxicity.

Authors:  Ian D Wilson; Jeremy K Nicholson
Journal:  Transl Res       Date:  2016-08-13       Impact factor: 7.012

3.  5-(Hydroxyimino)-4-methoxy-2-(pivaloylimino)thiazolidine-3 -acetamide, a reduced nitroheterocyclic derivative with potent schistosomicidal properties.

Authors:  P J Islip; M V Bogunović-Batchelor
Journal:  Experientia       Date:  1985-10-15

Review 4.  Developing a metagenomic view of xenobiotic metabolism.

Authors:  Henry J Haiser; Peter J Turnbaugh
Journal:  Pharmacol Res       Date:  2012-08-09       Impact factor: 7.658

5.  Relationship between metronidazole metabolism and bactericidal activity.

Authors:  E J Chrystal; R L Koch; M A McLafferty; P Goldman
Journal:  Antimicrob Agents Chemother       Date:  1980-10       Impact factor: 5.191

6.  Interaction of metronidazole with resistant and susceptible Bacteroides fragilis.

Authors:  M A McLafferty; R L Koch; P Goldman
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

Review 7.  Individual variation in first-pass metabolism.

Authors:  Y K Tam
Journal:  Clin Pharmacokinet       Date:  1993-10       Impact factor: 6.447

8.  Metronidazole metabolism in cultures of Entamoeba histolytica and Trichomonas vaginalis.

Authors:  B B Beaulieu; M A McLafferty; R L Koch; P Goldman
Journal:  Antimicrob Agents Chemother       Date:  1981-09       Impact factor: 5.191

Review 9.  The influence of gut microbiota on drug metabolism and toxicity.

Authors:  Houkai Li; Jiaojiao He; Wei Jia
Journal:  Expert Opin Drug Metab Toxicol       Date:  2015-12-10       Impact factor: 4.481

10.  Overexpression of the rhamnose catabolism regulatory protein, RhaR: a novel mechanism for metronidazole resistance in Bacteroides thetaiotaomicron.

Authors:  Ekta H Patel; Lynthia V Paul; Ana I Casanueva; Sheila Patrick; Valerie R Abratt
Journal:  J Antimicrob Chemother       Date:  2009-06-13       Impact factor: 5.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.